Back
Speaker illustration

Doctor Tim Anthonie Christiaan de Vries

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

Member of:

European Society of Cardiology

Tim A.C. de Vries is a medical doctor, currently working at the Amsterdam UMC location AMC as a PhD candidate/physician-scientist. With his research he aims to provide further insights into the use of oral anticoagulation in patients with atrial fibrillation in routine clinical practice, as well as into the role of inflammation in this common arrhythmia.

Presentations

Edoxaban for stroke prevention in routine practice patients with atrial fibrillation with and without atherosclerotic disease: a post-hoc sub-study of ETNA-AF-Europe

Event: ESC Congress 2024

Topic: Anticoagulants

Session: Novel anticoagulants and indications

Access
Like
Thumbnail

Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe

Event: ESC Congress 2022

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular disease in the elderly 2

Access
Like
Thumbnail

The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe

Event: ESC Congress 2022

Topic: Oral Anticoagulation

Session: Stroke prevention in atrial fibrillation

Access
Like
Thumbnail

Outcomes of edoxaban-treated patients with atrial fibrillation and concomitant vascular disease in daily clinical practice: insights from ETNA-AF-Europe

Event: EHRA 2021

Topic: Oral Anticoagulation

Session: Prevention of stroke in atrial fibrillation

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources